These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29980024)

  • 1. LC/QTOF/MS/MS characterization, molecular docking and in silico toxicity prediction studies on degradation products of anagliptin.
    Baira SM; Sigalapalli DK; Bathini NB; R S; Talluri MVNK
    J Pharm Biomed Anal; 2018 Sep; 159():92-99. PubMed ID: 29980024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
    Kalariya PD; Talluri MV; Patel PN; Srinivas R
    J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products.
    Johnsirani P; Wani AA; Bharatam PV; Nanjappan S
    J Pharm Biomed Anal; 2020 Jan; 177():112881. PubMed ID: 31542419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
    Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
    J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of forced degradation products of canagliflozine by liquid chromatography/quadrupole time-of-flight tandem mass spectrometry and in silico toxicity predictions.
    Baira SM; Kalariya PD; Nimbalkar R; Garg P; Srinivas R; Talluri MVNK
    Rapid Commun Mass Spectrom; 2018 Feb; 32(3):212-220. PubMed ID: 29134712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor.
    Swain D; Samanthula G; Bhagat S; Bharatam PV; Akula V; Sinha BN
    J Pharm Biomed Anal; 2016 Feb; 120():352-63. PubMed ID: 26771133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of degradation behavior of besifloxacin, characterization of its degradation products by LC-ESI-QTOF-MS and their in silico toxicity prediction.
    Salunke N; Kharkar PS; Pandita N
    Biomed Chromatogr; 2019 Jun; 33(6):e4489. PubMed ID: 30652327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
    Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
    J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
    Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry.
    Lei Y; Jin B; Ma C; Zhang T; Li T
    J Pharm Biomed Anal; 2017 May; 139():221-231. PubMed ID: 28292681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
    Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
    J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
    Prajapati KJ; Kothari CS
    Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
    Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
    J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography electrospray ionization tandem mass spectrometry study of nilutamide and its stress degradation products: in silico toxicity prediction of degradation products.
    Ramesh Babu A; Borkar RM; Raju G; Raju B; Srinivas R
    Biomed Chromatogr; 2014 Jun; 28(6):788-93. PubMed ID: 24861745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of forced degradation products of pralatrexate injection by LC-PDA and LC-MS.
    Sastry RVRP; Venkatesan CS; Sastry BS; Mahesh K
    J Pharm Biomed Anal; 2016 Nov; 131():400-409. PubMed ID: 27643862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
    Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
    J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
    Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
    Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).
    Liu M; Wang J; Liu P
    J Pharm Biomed Anal; 2016 Nov; 131():429-435. PubMed ID: 27661436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.